Track Becton, Dickinson And - 6% PRF CONVERT 01/06/2023 USD 50 - Ser B's other current liabilities ($6.1B) with charts, peers, and YoY trends.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
As of the most recent data (June 2026), BDXB shows a other current liabilities of $6.1B. In the prior-year period, the figure was $0. Scroll down for historical charts and peer comparison views.
Compared with the year-ago period, BDXB's other current liabilities is now $6.1B (was $0). Pairing that YoY change with peer averages gives a clearer picture of whether Becton, Dickinson And - 6% PRF CONVERT 01/06/2023 USD 50 - Ser B is outperforming or lagging.
Tracking BDXB's other current liabilities over time shows whether Becton, Dickinson And - 6% PRF CONVERT 01/06/2023 USD 50 - Ser B is scaling, shrinking, or reshaping that part of the business. The current reading is $6.1B In the prior-year period, the figure was $0. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.
Besides this other current liabilities page, Stockcircle has Becton, Dickinson And - 6% PRF CONVERT 01/06/2023 USD 50 - Ser B's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect other current liabilities (currently $6.1B) with ownership activity and broader fundamentals.
Becton, Dickinson And - 6% PRF CONVERT 01/06/2023 USD 50 - Ser B's other current liabilities is $6.1B; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.